Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Clarivate, Lowers Price Target to $11

Morgan Stanley analyst Toni Kaplan maintains Clarivate (NYSE:CLVT) with a Overweight and lowers the price target from $13 to $11.
byBenzinga Newsdesk
January 4, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Toni Kaplan maintains Clarivate (NYSE:CLVT) with a Overweight and lowers the price target from $13 to $11.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts